Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Paroxetine

Criteria

Inclusion Criteria:

• Subjects who are diagnosed as having SAD

• Subjects who are expected to use paroxetine tablets for the first time

Exclusion Criteria:

• Subjects taking pimozide

• Subjects taking monoamine oxidase (MAO) inhibitor or within two weeks after discontinuation of MAO inhibitor

• Subjects with hypersensitivity to paroxetine